US Stock MarketDetailed Quotes

ATXI Avenue Therapeutics

Watchlist
  • 1.8500
  • 0.00000.00%
Close Jan 21 16:00 ET
  • 1.8000
  • -0.0500-2.70%
Post 16:07 ET
3.80MMarket Cap-0.16P/E (TTM)

Avenue Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
52.61%3.16M
-28.04%2.82M
-42.32%3.71M
80.78%14.54M
-45.83%2.12M
211.92%2.07M
548.43%3.92M
124.55%6.43M
115.17%8.04M
328.01%3.91M
Selling and administrative expenses
-28.60%829K
63.17%1.46M
33.74%1.32M
-21.81%4.18M
-66.23%1.14M
147.55%1.16M
97.36%896K
-6.73%984K
115.18%5.35M
542.56%3.37M
-General and administrative expense
-28.60%829K
63.17%1.46M
33.74%1.32M
-21.81%4.18M
-66.23%1.14M
147.55%1.16M
97.36%896K
-6.73%984K
115.18%5.35M
542.56%3.37M
Research and development costs
156.56%2.33M
-55.04%1.36M
-56.07%2.39M
284.03%10.36M
80.18%982K
367.53%907K
1,904.64%3.03M
201.16%5.45M
115.15%2.7M
39.74%545K
Operating profit
-52.61%-3.16M
28.04%-2.82M
42.32%-3.71M
-80.78%-14.54M
45.83%-2.12M
-211.92%-2.07M
-548.43%-3.92M
-124.55%-6.43M
-115.17%-8.04M
-328.01%-3.91M
Net non-operating interest income expense
466.67%51K
-8.77%52K
116.61%49K
81.93%-206K
101.92%22K
800.00%9K
5,600.00%57K
-14,850.00%-295K
-16,385.71%-1.14M
-114,500.00%-1.14M
Non-operating interest income
466.67%51K
-8.77%52K
32.43%49K
530.00%126K
37.50%22K
800.00%9K
5,600.00%57K
1,750.00%37K
185.71%20K
1,500.00%16K
Non-operating interest expense
--0
--0
--0
-71.38%332K
--0
--0
--0
--332K
--1.16M
--1.16M
Other net income (expense)
-99.30%18K
146.67%70K
21.41%-690K
-23.69%4.26M
2.71M
2.57M
-150K
-878K
5.58M
Gain on sale of security
-99.30%18K
146.67%70K
21.41%-690K
-23.69%4.26M
--2.71M
--2.57M
---150K
---878K
--5.58M
----
Income before tax
-701.75%-3.09M
32.74%-2.7M
42.79%-4.35M
-191.09%-10.49M
17.75%617K
177.49%513K
-564.90%-4.02M
-165.71%-7.6M
3.43%-3.6M
157.39%524K
Income tax
Net income
-701.75%-3.09M
32.74%-2.7M
42.79%-4.35M
-191.09%-10.49M
17.75%617K
177.49%513K
-564.90%-4.02M
-165.71%-7.6M
3.43%-3.6M
157.39%524K
Net income continuous Operations
-701.75%-3.09M
32.74%-2.7M
42.79%-4.35M
-191.09%-10.49M
17.75%617K
177.49%513K
-564.90%-4.02M
-165.71%-7.6M
3.43%-3.6M
157.39%524K
Minority interest income
15.38%-11K
0.00%-9K
86.36%-9K
-117.65%-111K
54.90%-23K
-13K
-9K
-66K
-51K
-51K
Net income attributable to the parent company
-684.79%-3.08M
-79.34%-7.19M
42.41%-4.34M
-192.15%-10.38M
11.30%640K
179.46%526K
-563.41%-4.01M
-163.40%-7.54M
4.80%-3.55M
162.98%575K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-684.79%-3.08M
-79.34%-7.19M
42.41%-4.34M
-192.15%-10.38M
11.30%640K
179.46%526K
-563.41%-4.01M
-163.40%-7.54M
4.80%-3.55M
162.98%575K
Basic earnings per share
-139.51%-1.92
83.40%-6.43
84.84%-15.4
39.88%-73.5
-79.24%1.8752
114.40%4.86
-25.98%-38.74
33.94%-101.57
50.46%-122.25
116.28%9.0336
Diluted earnings per share
-139.51%-1.92
83.40%-6.43
84.84%-15.4
39.88%-73.5
-79.24%1.8752
114.40%4.86
-25.98%-38.74
33.94%-101.57
50.46%-122.25
116.28%9.0336
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 52.61%3.16M-28.04%2.82M-42.32%3.71M80.78%14.54M-45.83%2.12M211.92%2.07M548.43%3.92M124.55%6.43M115.17%8.04M328.01%3.91M
Selling and administrative expenses -28.60%829K63.17%1.46M33.74%1.32M-21.81%4.18M-66.23%1.14M147.55%1.16M97.36%896K-6.73%984K115.18%5.35M542.56%3.37M
-General and administrative expense -28.60%829K63.17%1.46M33.74%1.32M-21.81%4.18M-66.23%1.14M147.55%1.16M97.36%896K-6.73%984K115.18%5.35M542.56%3.37M
Research and development costs 156.56%2.33M-55.04%1.36M-56.07%2.39M284.03%10.36M80.18%982K367.53%907K1,904.64%3.03M201.16%5.45M115.15%2.7M39.74%545K
Operating profit -52.61%-3.16M28.04%-2.82M42.32%-3.71M-80.78%-14.54M45.83%-2.12M-211.92%-2.07M-548.43%-3.92M-124.55%-6.43M-115.17%-8.04M-328.01%-3.91M
Net non-operating interest income expense 466.67%51K-8.77%52K116.61%49K81.93%-206K101.92%22K800.00%9K5,600.00%57K-14,850.00%-295K-16,385.71%-1.14M-114,500.00%-1.14M
Non-operating interest income 466.67%51K-8.77%52K32.43%49K530.00%126K37.50%22K800.00%9K5,600.00%57K1,750.00%37K185.71%20K1,500.00%16K
Non-operating interest expense --0--0--0-71.38%332K--0--0--0--332K--1.16M--1.16M
Other net income (expense) -99.30%18K146.67%70K21.41%-690K-23.69%4.26M2.71M2.57M-150K-878K5.58M
Gain on sale of security -99.30%18K146.67%70K21.41%-690K-23.69%4.26M--2.71M--2.57M---150K---878K--5.58M----
Income before tax -701.75%-3.09M32.74%-2.7M42.79%-4.35M-191.09%-10.49M17.75%617K177.49%513K-564.90%-4.02M-165.71%-7.6M3.43%-3.6M157.39%524K
Income tax
Net income -701.75%-3.09M32.74%-2.7M42.79%-4.35M-191.09%-10.49M17.75%617K177.49%513K-564.90%-4.02M-165.71%-7.6M3.43%-3.6M157.39%524K
Net income continuous Operations -701.75%-3.09M32.74%-2.7M42.79%-4.35M-191.09%-10.49M17.75%617K177.49%513K-564.90%-4.02M-165.71%-7.6M3.43%-3.6M157.39%524K
Minority interest income 15.38%-11K0.00%-9K86.36%-9K-117.65%-111K54.90%-23K-13K-9K-66K-51K-51K
Net income attributable to the parent company -684.79%-3.08M-79.34%-7.19M42.41%-4.34M-192.15%-10.38M11.30%640K179.46%526K-563.41%-4.01M-163.40%-7.54M4.80%-3.55M162.98%575K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -684.79%-3.08M-79.34%-7.19M42.41%-4.34M-192.15%-10.38M11.30%640K179.46%526K-563.41%-4.01M-163.40%-7.54M4.80%-3.55M162.98%575K
Basic earnings per share -139.51%-1.9283.40%-6.4384.84%-15.439.88%-73.5-79.24%1.8752114.40%4.86-25.98%-38.7433.94%-101.5750.46%-122.25116.28%9.0336
Diluted earnings per share -139.51%-1.9283.40%-6.4384.84%-15.439.88%-73.5-79.24%1.8752114.40%4.86-25.98%-38.7433.94%-101.5750.46%-122.25116.28%9.0336
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Oracle
ORCL
+7.17%
Micron Technology
MU
+3.43%
Taiwan Semiconductor
TSM
+3.40%
NVIDIA
NVDA
+2.27%
Amazon
AMZN
+2.11%

Unlock the Full List